Clinical Trials Browser

OTHER_GOV × Radiation × Clear all

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT07037576 2025-06-25

Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study

Breast Neoplasms

NCT05000710 2024-12-05

CORAL-Lung

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT05628610 2024-08-13

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

Phase 2 Not yet recruiting

Gastrointestinal

Esophageal Neoplasms

NCT05088889 2023-11-28

Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer

Phase 1 Unknown

Gastrointestinal

Pancreatic Neoplasms

NCT05624099 2023-10-19

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Phase 2 Recruiting

Gastrointestinal

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

NCT05007145 2021-12-21

REVO

Phase 2 Unknown

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04488614 2020-07-30

PBCB

Enrolling by invitation

Breast Neoplasms, Fatigue

NCT04220528 2020-01-07

Radical Radiotherapy and Chemotherapy Combined With Maintenance Chemotherapy in the Treatment of Stage N3 NPC

Phase 2 Unknown

Nasopharyngeal Carcinoma

NCT02890316 2019-04-09

Assessment of Fatigue During Radiotherapy for Breast Cancer With and Without Homeopathy Treatment

Phase NA Completed

Breast Neoplasms

NCT03412526 2019-04-04

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

Phase 2 Unknown

Ovarian Neoplasms

NCT03666221 2018-09-11

Nimotuzumab for Recurrent Nasopharyngeal Carcinoma

Phase 2 Unknown

Nasopharyngeal Carcinoma, Recurrence

NCT00864331 2013-08-07

Optimization of Treatment of Advanced Nonsmall Cell Lung Cancer Using Radiotherapy and Chemotherapy

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00781209 2008-10-28

The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases

Phase 2 Unknown

Neoplasm Metastasis